Request Media Kit

Jane-Ome, Marijuana iPad App Looks To Educate Users On Scientific Benefits

Everything is better with marijuana; this is the argument many users make and has been featured in a certain stoner comedy (hilariously played by Jon Stewart). However, many people are unaware of the ...
Jane-Ome, Marijuana iPad App Looks To Educate Users On Scientific Benefits
Written by
  • Everything is better with marijuana; this is the argument many users make and has been featured in a certain stoner comedy (hilariously played by Jon Stewart). However, many people are unaware of the true benefits marijuana has in the medical community, and how it can truly make life a bit better for people with various health problems.

    Medical Genomics looks to inform the masses, with a major step being the release of an iPad app which will inform users of their research. What are they researching? They’ve been sequencing entire cannabis genomes and mapping them for research. Their app will feature a wide array of functions, which you can read about below. If you decide to download the app, it will set you back $1.99.

    MARBLEHEAD, Mass. – January 12, 2012 – Medicinal Genomics, a pioneer in the genomics of medicinal plants, today announced the availability of Jane-Ome, an application designed for Apple’s iPad tablet, which offers a science-based dissection of medical marijuana.

    Jane-Ome provides a gateway to the Cannabis genome project led by Medicinal Genomics, which in August 2011 sequenced the entire genome of Cannabis sativa and Cannabis indica, assembling the largest known gene collection of this therapeutic plant.

    “Medicinal Genomics is excited to roll out Jane-Ome to help make sense of the extensive datasets created by the Cannabis genome project,” said Kevin McKernan, founder and head of scientific operations of Medicinal Genomics. “The company’s hope is that Jane-Ome will help make that data more relevant to the public and serve as a conduit for future Cannabis genomes.”

    Jane-Ome provides users with continuously updated, exclusive genomic information on various Cannabis genomes. In addition, the app provides users with access to several scientific news feeds that explore the science of medicinal Cannabis, making Jane-Ome the nerve center to explore the plant’s therapeutic potential.

    In addition to its encyclopedic information about the bleeding-edge science of Cannabis, Jane-Ome users can compete in Cannabis related trivia to earn the right to guide future sequencing efforts. Users can also explore never before released blueprints for the equipment used to crack the human genome project, as well as access videos which explain the impact DNA sequencing and genomics have had on the world. Furthermore, Jane-Ome provides users with access to never before seen videos documenting the history of the human genome project, as well as commentary from members of that scientific consortium explaining how research has led them to aim their sights on unlocking the genome of Cannabis.

    One of the more interesting reads from their press release is the medical benefits they list from cannabis use – “Ongoing scientific research suggests that the Cannabis plant harbors beneficial compounds as it pertains to cancer apoptosis, antiemesis for HIV and chemotherapy patients, reduction of muscle spasms for multiple sclerosis patients, as well as the treatment of glaucoma, inflammatory diseases, anxiety, and post-traumatic stress disorder, among other health conditions.

    Of the 85 identified Cannabinoids in the plant, only one is independently psychoactive. The other 84 appear to be non-psychoactive and are still powerful therapeutics. Many Cannabinoids have been bred to low expression levels over the years but are excellent small molecule therapeutic drug candidates for cancer and inflammatory diseases. The genome sequence can be utilized to design breeding strategies to resurrect these nearly extinct pathways. In addition, Cannabinoids have also been shown to have a very favorable therapeutic index making them a unique class of anti-cancer compounds because the lethal dose is much higher than the effective dose. Furthermore, Cannabinoids are less addictive analgesics than opiates, and target different pain pathways in the body.

    Get the WebProNews newsletter delivered to your inbox

    Get the free daily newsletter read by decision makers

    Subscribe
    Advertise with Us

    Ready to get started?

    Get our media kit